Table II.
Year | N | FU, mo | Complication, % | Revision, % | Reoperation, % | |
---|---|---|---|---|---|---|
Authors | ||||||
Black et al2: primary | 2014 | 33 | 55 | 18 | 6 | 3 |
Black et al: revision | 2014 | 32 | 56 | 28 | 3 | 9 |
Ek et al7 | 2013 | 40 | 93 | 38 | 23 | 28 |
Leathers et al16 | 2018 | 32 | 41 | 9 | 0 | 0 |
Matthews et al18 | 2019 | 43 | 50 | 2 | 0 | 0 |
Muh et al21 | 2013 | 67 | 37 | 13 | 7 | 4 |
Otto et al22: primary | 2017 | 32 | 60 | 19 | 13 | 3 |
Otto et al: revision | 2017 | 35 | 65 | 26 | 9 | 3 |
Samuelsen et al28 | 2017 | 67 | 36 | 7 | 3 | 1 |
Sershon et al29 | 2014 | 36 | 34 | 17 | 11 | 3 |
Weighted mean | 2016 | 417 | 50 | 16.5 | 7.2 | 5.3 |
Minimum mean | 2013 | 32 | 34 | 2 | 0 | 0 |
Maximum mean | 2019 | 67 | 93 | 38 | 23 | 28 |
FU, follow-up duration.